Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Angion Biomedica Corp. | ex322_angnx123120x10k.htm |
| EX-32.1 - EX-32.1 - Angion Biomedica Corp. | ex321angn-12312020x10k.htm |
| EX-31.2 - EX-31.2 - Angion Biomedica Corp. | ex312_angnx123120x10k.htm |
| EX-31.1 - EX-31.1 - Angion Biomedica Corp. | ex311_angnx123120-10k.htm |
| EX-4.7 - EX-4.7 - Angion Biomedica Corp. | a47angion-ex4xxdescription.htm |
| 10-K - 10-K - Angion Biomedica Corp. | angn-12312020x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-252906) of our report dated March 30, 2021, relating to the consolidated financial statements of Angion Biomedica Corp., appearing in this Annual Report (Form 10-K) for the year ended December 31, 2020.
/s/ Moss Adams LLP
Seattle, Washington
March 30, 2021